ALPA

Alpa Laboratories Share Price

₹112.31 +3.77 (3.47%)

18 Nov, 2024 20:03

SIP TrendupStart SIP in ALPA

Start SIP

Performance

  • Low
  • ₹109
  • High
  • ₹113
  • 52 Week Low
  • ₹70
  • 52 Week High
  • ₹145
  • Open Price₹113
  • Previous Close₹109
  • Volume25,834

Investment Returns

  • Over 1 Month -5.23%
  • Over 3 Month + 15.71%
  • Over 6 Month + 25.84%
  • Over 1 Year + 18.41%
SIP Lightning

Smart Investing Starts Here Start SIP with Alpa Laboratories for Steady Growth!

Invest Now

Alpa Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 11.3
  • PEG Ratio
  • 0.9
  • Market Cap Cr
  • 236
  • P/B Ratio
  • 1.6
  • Average True Range
  • 4.91
  • EPS
  • 9.9
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.47
  • RSI
  • 49.03
  • MFI
  • 44.97

Alpa Laboratories Financials

Alpa Laboratories Technicals

EMA & SMA

Current Price
₹112.31
+ 3.77 (3.47%)
pointer
  • stock-down_img
  • Bullish Moving Average 12
  • stock-up_img
  • Bearish Moving Average 4
  • 20 Day
  • ₹112.26
  • 50 Day
  • ₹112.37
  • 100 Day
  • ₹108.04
  • 200 Day
  • ₹101.23

Resistance and Support

111.47 Pivot Speed
  • R3 117.74
  • R2 115.37
  • R1 113.84
  • S1 109.94
  • S2 107.57
  • S3 106.04

What's your outlook on Alpa Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Alpa Laboratories has an operating revenue of Rs. 97.30 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 19% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 9% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 92 which is a GREAT score indicating consistency in earnings, a RS Rating of 59 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 38 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Alpa Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-13 Quarterly Results & A.G.M.
2024-05-28 Audited Results
2024-02-13 Quarterly Results
2023-11-07 Quarterly Results

Alpa Laboratories F&O

Alpa Laboratories Shareholding Pattern

57.29%
0.74%
36.09%
5.88%

About Alpa Laboratories

  • NSE Symbol
  • ALPA
  • BSE Symbol
  • 532878
  • Managing Director
  • Mr. Paresh Chawla
  • ISIN
  • INE385I01010

Similar Stocks to Alpa Laboratories

Alpa Laboratories FAQs

Alpa Laboratories share price is ₹112 As on 18 November, 2024 | 19:49

The Market Cap of Alpa Laboratories is ₹236.3 Cr As on 18 November, 2024 | 19:49

The P/E ratio of Alpa Laboratories is 11.3 As on 18 November, 2024 | 19:49

The PB ratio of Alpa Laboratories is 1.6 As on 18 November, 2024 | 19:49

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23